Performance Evaluation of VIDAS® Diagnostic Assays Detecting Anti-Chikungunya Virus IgM and IgG Antibodies: An International Study

Pereira, Geovana M.; Manuli, Erika R.; Coulon, Laurie; Côrtes, Marina F.; Ramundo, Mariana S.; Dromenq, Loïc; Larue-Triolet, Audrey; Raymond, Frédérique; Tourneur, Carole; Lázari, Carolina dos Santos; Brasil, Patricia; Filippis, Ana Maria Bispo de; Paranhos-Baccalà, Glaucia; Banz, Alice; Sabino, Ester C..
Artículo en Inglés | ARCA | ID: arc-60706

Documentos relacionados

  1. [Anti-Golgi antibodies: let me look around].
  2. [SARS-CoV-2 neutralizing monoclonal antibodies: a potential breakthrough in the early treatment of Covid-19 in high-risk patients].
  3. [Cytomegalovirus antibodies: review of results of repeated examinations in 208 hemodialyzed patients].
  4. [Bispecific monoclonal antibodies: the isolation and study of their antigen-binding properties].
  5. [Detection of specific toxoplasma class A antibodies: a comparison of diagnostic usefulness of commercially available diagnostic kits].
  6. [Anti-endomysium antibodies: a new marker for the diagnosis and treatment of celiac disease].
  7. [Monoclonal antibodies: therapeutic possibilities and limitations].
  8. [Epstein-Barr virus antibodies: review of results from repeated examinations in 208 hemodialyzed patients].
  9. [Antiendomysial antibodies: current role in the diagnosis of celiac disease compared to antigliadin antibodies].
  10. [Immunoscintigraphy using 111In-DTPA-labeled monoclonal antibodies: comparison with ECT and planar scintigraphy].